| Literature DB >> 28386242 |
Francisco J Cano-García1, María Del Carmen González-Ortega1, Susana Sanduvete-Chaves2, Salvador Chacón-Moscoso3, Roberto Moreno-Borrego4.
Abstract
According to evidence from recent decades, multicomponent programs of psychological intervention in people with chronic pain have reached the highest levels of efficacy. However, there are still many questions left to answer since efficacy has mainly been shown among upper-middle class patients in English-speaking countries and in controlled studies, with expert professionals guiding the intervention and with a limited number of domains of painful experience evaluated. For this study, a program of multicomponent psychological intervention was implemented: (a) based on techniques with empirical evidence, but developed in Spain; (b) at a public primary care center; (c) among patients with limited financial resources and lower education; (d) by a novice psychologist; and (e) evaluating all domains of painful experience using the instruments recommended by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT). The aim of this study was to evaluate this program. We selected a consecutive sample of 40 patients treated for chronic non-cancer pain at a primary care center in Utrera (Seville, Spain), adults who were not in any employment dispute, not suffering from psychopathology, and not receiving psychological treatment. The patients participated in 10 psychological intervention sessions, one per week, in groups of 13-14 people, which addressed psychoeducation for pain; breathing and relaxation; attention management; cognitive restructuring; problem-solving; emotional management; social skills; life values and goal setting; time organization and behavioral activation; physical exercise promotion; postural and sleep hygiene; and relapse prevention. In addition to the initial assessment, measures were taken after the intervention and at a 6-month follow-up. We assessed the program throughout the process: before, during and after the implementation. Results were analyzed statistically (significance and effect size) and from a clinical perspective (clinical significance according to IMMPACT standards). According to this analysis, the intervention was successful, although improvement tended to decline at follow-up, and the detailed design gave the program assessment a high degree of standardization and specification. Finally, suggestions for improvement are presented for upcoming applications of the program.Entities:
Keywords: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT); chronic pain; clinical effectiveness; formative evaluation; methodological quality; primary care
Year: 2017 PMID: 28386242 PMCID: PMC5362736 DOI: 10.3389/fpsyg.2017.00435
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Reliability.
| Pre-test | Post-test | Follow-up | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| WHYMPI | 0.728 | 40 | 0.796 | 4.902 | <0.001 | 0.744 | 29 | 0.795 | 4.883 | <0.001 | 0.765 | 21 | 0.922 | 12.766 | <0.001 |
| POMS-F | 0.717 | 38 | 0.732 | 3.735 | <0.001 | 0.800 | 29 | 0.814 | 5.385 | <0.001 | 0.889 | 18 | 0.902 | 10.210 | <0.001 |
| POMS-D | 0.845 | 38 | 0.853 | 6.820 | <0.001 | 0.907 | 29 | 0.914 | 11.580 | <0.001 | 0.878 | 20 | 0.891 | 9.161 | <0.001 |
| POMS-T | 38 | 3.165 | <0.001 | 0.782 | 29 | 0.798 | 4.940 | <0.001 | 20 | 3.021 | <0.001 | ||||
| POMS-H | 0.829 | 38 | 0.838 | 6.182 | <0.001 | 0.886 | 29 | 0.894 | 9.447 | <0.001 | 0.705 | 18 | 0.740 | 3.842 | <0.001 |
| POMS-C | 0.765 | 38 | 0.778 | 4.498 | <0.001 | 0.766 | 29 | 0.783 | 4.602 | <0.001 | 0.819 | 19 | 0.839 | 6.215 | <0.001 |
| POMS-V | 0.701 | 38 | 0.717 | 3.536 | <0.001 | 0.804 | 29 | 0.818 | 5.495 | <0.001 | 0.739 | 18 | 0.770 | 4.342 | <0.001 |
| POMS-M | 0.932 | 38 | 0.936 | 15.546 | <0.001 | 0.960 | 29 | 0.963 | 26.923 | <0.001 | 0.978 | 15 | 0.981 | 53.030 | <0.001 |
| BDI | 0.876 | 38 | 0.883 | 8.525 | <0.001 | 0.852 | 29 | 0.863 | 7.277 | <0.001 | 0.860 | 20 | 0.875 | 7.983 | <0.001 |
Global comparison at the different instances of measurement, trend contrasts and clinical significance when comparing pre-test to post-test and to follow-up.
| Variable | Pre-test | Post-test | Follow-up | Global | fClinical significance | Linear trend | Quadratic trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Statistic | ES | Pre–post | Pre-follow-up | Statistic | ES | Statistic | ES | ||||||||
| 24-h Inten | 7.52 | 1.03 | 4.95 | 1.72 | 6.76 | 2.36 | 21 | b19.9*** | d0.47+++ | 2.57 ♠ | 0.76 | h[-0.0140, 1.054] | — | h | — |
| Pr Inten | 6.71 | 1.23 | 4.05 | 1.56 | 5 | 2.88 | 21 | a,c10.37** | e0.3+++ | 2.66♠ | 1.71 ♠ | c5.6* | e0.13++ | c24.24*** | e0.25+++ |
| 24-h Inter | 2.43 | 0.55 | 1.52 | 0.91 | 2.24 | 0.89 | 21 | b10.26** | d0.24+++ | — | — | h | — | h | — |
| Pr Inter | 2.33 | 0.66 | 1.52 | 0.87 | 1.52 | 1.08 | 21 | b14.06** | d0.34+++ | — | — | h | — | h[-0.205, 2.275] | — |
| WHYMPI | 4.12 | 0.73 | 3.33 | 0.74 | 3.7 | 0.86 | 21 | c9.62*** | e0.15+++ | 0.79♠♠♠ | 0.42♠♠ | c5.08* | e0.06++ | c14.62** | e0.13++ |
| POMS-F | 15.33 | 5.76 | 10 | 5.29 | 13.63 | 7.28 | 18 | c4.59* | e0.1++ | 5.33♠♠♠ | 1.7♠♠ | c0.75 | e0.01+ | c7.6* | e0.11++ |
| POMS-D | 22.65 | 10.96 | 14.40 | 11.05 | 20.70 | 16.46 | 20 | c4.60 | e0.07++ | 8.25♠♠♠ | 1.95♠♠ | c0.428 | e0.01+ | c9.673** | e0.08++ |
| POMS-T | 19.15 | 4.74 | 15.20 | 7.01 | 17.05 | 9.15 | 20 | c3.26 | e0.05++ | 3.95♠♠♠ | 2.10♠♠♠ | c1.63 | e0.02+ | c0.355* | e0.04+ |
| POMS-H | 20.06 | 8.01 | 14 | 9.41 | 16.50 | 12.55 | 18 | c3.34 | e0.06++ | 6.06♠♠♠ | 3.56♠♠♠ | c2.241 | e0.02+ | c4.476* | e0.05++ |
| POMS-C | 13.47 | 5.89 | 9.89 | 5.42 | 11.95 | 6.75 | 19 | c4.03* | e0.06++ | 3.58♠♠♠ | 1.52♠ | c1.678 | e0.01+ | c5.818* | e0.05++ |
| POMS-V | 10.89 | 4.78 | 16.37 | 6.49 | 13.42 | 4.83 | 18 | b12.10** | d0.32+++ | -5.48♠♠♠ | –2.53♠♠♠ | h | — | h | — |
| POMS-M | 81.40 | 36.81 | 47.33 | 41.17 | 73.33 | 52.77 | 15 | c5.03* | e0.1++ | 34.07♠♠♠ | 8.07♠♠ | c0.583 | e0.01+ | c8.548* | e0.14++ |
| BDI | 17.95 | 10.36 | 10.15 | 7.62 | 33.45 | 8.61 | 20 | b31.3*** | d0.78+++ | — | — | h | — | h | — |
| PGIC | 5.00 | 0 | 6.20 | 0.70 | 5.85 | 0.93 | 20 | b22.07*** | d0.55+++ | g♠♠ | g♠♠ | h | — | h | — |
Improvement perceived by patients after the intervention in the Patient Global Impression of Change (PGIC) scale.
| Category | Post ( | Follow-up ( | |||
|---|---|---|---|---|---|
| % | % | ||||
| No change | 4 | 0 | 0 | 2 | 10 |
| Minimally improved♠ | 5 | 3 | 10.3 | 4 | 20 |
| Much improved♠♠ | 6 | 17 | 58.6 | 9 | 45 |
| Very much improved♠♠♠ | 7 | 9 | 31 | 5 | 25 |